Proposed Collection; Comment Request; Process Evaluation of the NIH Roadmap Epigenomics Program, 13648-13649 [2011-5786]
Download as PDF
<![CDATA[
13648
Federal Register / Vol. 76, No. 49 / Monday, March 14, 2011 / Notices
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Heather Bowles,
Risk Factor Monitoring and Methods
Branch, Division of Cancer Control and
Population Sciences, National Cancer
Institute, 6130 Executive Blvd MSC
7344, Bethesda, MD 20892–7335 or call
non-toll-free number 301–496–7344 or
e-mail your request, including your
address to: bowleshr@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60 days of the date of
this publication.
Dated: March 8, 2011.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2011–5800 Filed 3–11–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment
Request; Process Evaluation of the
NIH Roadmap Epigenomics Program
Summary: In compliance with the
requirement of Section 3506(c)(2)(A) of
the Paperwork Reduction Act of 1995,
for opportunity for public comment on
proposed data collection projects, the
National Institute of Drug Abuse
(NIDA), the National Institutes of Health
(NIH), will publish periodic summaries
of proposed projects to be submitted to
the Office of Management and Budget
(OMB) for review and approval.
Proposed Collection
Title: Process Evaluation of the NIH
Roadmap Epigenomics Program.
Type of Information Collection
Request: New.
Need and Use of Information
Collection: The proposed information
collection is essential to the process
evaluation of the NIH Roadmap
Epigenomics Program. The process
evaluation is a requirement of each
awardee funded under the NIH
Roadmap Epigenomics Program. This
participation requirement is stated in
the program’s Requests for Applications.
This evaluation study, a mixedmethods study which uses secondary
source documentation and information
from tracking and monitoring systems
along with primary data to assess
program process and progress, is nonexperimental. The assessment is based
on secondary source information, with
primary source information collection
added to augment the reliability and
internal validity. The primary data
collection uses information categories
that genuinely tap added distinctions
and opinions that relate to it to build the
weight of evidence from first-hand
sources and substantiate the initial
hypotheses about the program
phenomenon and its differences from a
typical research portfolio of individual
and insular projects.
The synthesized results across
primary and secondary data sources will
provide critical insights on
transformativeness of high-impact,
trans-NIH programs and contribute
important information about the
synergies and collaborations in multicomponent scientific research. It will
also identify areas for program
improvement and lessons learned that
might be useful to other research
programs of the Agency.
To reduce response bias and to make
the survey as accessible as possible to
busy principal investigators, the survey
will be Web-based.
Frequency of Response: Once.
Affected Public: Principal
Investigators of the program at not-forprofit institutions.
Type of Respondents: Principal
Investigators.
The annual reporting burden is as
follows:
Estimated number of Respondents:
53.
Estimated Number of Responses per
Respondent: 1.
Average Burden Hours Per Response:
0.33.
Estimated Total Annual Burden
Hours Requested: 17.49.
The annualized cost to respondents is
estimated at: $891.99.
There are no Capital Costs, Operating
Costs and/or Maintenance Costs to
report.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of respondents
Type of respondent
Frequency of
responses per
respondent
Average burden hours
per response
Annual burden
hours
requested
53
1
0.33 (20 minutes) .......
17.49
mstockstill on DSKH9S0YB1PROD with NOTICES
Principal Investigators .........................................................................
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies are invited
on one or more of the following points:
(1) Whether the proposed collection of
information is necessary for the proper
performance of the function of the
agency, including whether the
information will have practical utility;
(2) The accuracy of the agency’s
estimate of the burden of the proposed
VerDate Mar<15>2010
16:20 Mar 11, 2011
Jkt 223001
collection of information, including the
validity of the methodology and
assumptions used; (3) Ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4)
Ways to minimize the burden of the
collection of information on those who
are to respond, including the use of
appropriate automated, electronic,
mechanical, or other technological
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
collection techniques or other forms of
information technology.
For Further Information Contact: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact Genevieve
deAlmeida-Morris, PhD, M.P.H., Project
Officer, Office of Science Policy and
Communications, NIH/NIDA, NSC—
Neuroscience Center, 5229, 6001
E:\FR\FM\14MRN1.SGM
14MRN1
Federal Register / Vol. 76, No. 49 / Monday, March 14, 2011 / Notices
Executive Blvd., Rockville, MD 20852 or
call non-toll-free number 301–594–6802
or e-mail your request including your
address to: dealmeig@nida.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 60-days of the date of
this publication.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: March 8, 2011.
Mary Affeldt,
Executive Officer (OM Director), NIDA.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2011–5786 Filed 3–11–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
mstockstill on DSKH9S0YB1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Martin Delaney
Collaboratory: Towards an HIV–1 Cure.
Date: April 4–6, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Silver Spring, 8727 Colesville
Road, Silver Spring, MD 20910.
Contact Person: Jay Bruce Sundstrom, PhD,
Scientific Review Officer, Scientific Review
Program, DEA/NIAID/NIH/DHHS, 6700B
Rockledge Drive, MSC–7616, Room 3119,
Bethesda, MD 20892–7616, 301–496–7042,
sundstromj@niaid.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 8, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–5798 Filed 3–11–11; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
16:20 Mar 11, 2011
Jkt 223001
National Institutes of Health
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Name of Committee: National Institute of
Child Health and Human Development
Special Emphasis Panel; Molecular and
Cellular Controls of Placental Metabolism.
Date: April 4, 2011.
Time: 2 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, 5B01, Rockville, MD
20852, (Telephone Conference Call)
Contact Person: Neelakanta Ravindranath,
PhD, Scientific Review Officer, Division of
Scientific Review, Eunice Kennedy Shriver
National Institute of Child Health and
Human Development, NIH, 6100 Executive
Blvd., Room 5B01, Bethesda, MD 20892,
301–496–1485, ravindm@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.864, Population Research;
93.865, Research for Mothers and Children;
93.929, Center for Medical Rehabilitation
Research; 93.209, Contraception and
Infertility Loan Repayment Program, National
Institutes of Health, HHS)
Dated: March 8, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–5795 Filed 3–11–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Arthritis and
Musculoskeletal And Skin Diseases;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
13649
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; Program
Project Grant Review.
Date: March 24, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Helen Lin, Scientific
Review Officer, Scientific Review Branch,
National Institute of Arthritis,
Musculoskeletal and Skin Diseases, National
Institutes of Health, 6701 Democracy Blvd.,
Suite 800, MSC 4872, Bethesda, MD 20892,
301–594–4952, linh1@mail.nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; Small
Grants Research Review.
Date: April 7, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, One
Democracy Plaza, 6701 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting)
Contact Person: Eric H. Brown, Scientific
Review Officer, Scientific Review Branch,
National Institute of Arthritis,
Musculoskeletal and Skin Diseases, National
Institutes of Health, 6701 Democracy Blvd.,
Suite 800, MSC 4872, Bethesda, MD 20892,
(301) 594–4955, browneri@mail.nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
Diseases Special Emphasis Panel; Rheumatic
Disease Center Core Review.
Date: April 13–14, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications,
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Michael L. Bloom, MBA,
PhD, Scientific Review Officer, Scientific
Review Branch, National Institute of
Arthritis, Musculoskeletal and Skin Diseases,
National Institutes of Health, 6701
Democracy Blvd., Suite 800, MSC 4872,
Bethesda, MD 20892, 301–594–4953,
bloomm2@mail.nih.gov.
Name of Committee: National Institute of
Arthritis and Musculoskeletal and Skin
E:\FR\FM\14MRN1.SGM
14MRN1
]]>Agencies
[Federal Register Volume 76, Number 49 (Monday, March 14, 2011)]
[Notices]
[Pages 13648-13649]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-5786]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Proposed Collection; Comment Request; Process Evaluation of the
NIH Roadmap Epigenomics Program
Summary: In compliance with the requirement of Section
3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity
for public comment on proposed data collection projects, the National
Institute of Drug Abuse (NIDA), the National Institutes of Health
(NIH), will publish periodic summaries of proposed projects to be
submitted to the Office of Management and Budget (OMB) for review and
approval.
Proposed Collection
Title: Process Evaluation of the NIH Roadmap Epigenomics Program.
Type of Information Collection Request: New.
Need and Use of Information Collection: The proposed information
collection is essential to the process evaluation of the NIH Roadmap
Epigenomics Program. The process evaluation is a requirement of each
awardee funded under the NIH Roadmap Epigenomics Program. This
participation requirement is stated in the program's Requests for
Applications.
This evaluation study, a mixed-methods study which uses secondary
source documentation and information from tracking and monitoring
systems along with primary data to assess program process and progress,
is non-experimental. The assessment is based on secondary source
information, with primary source information collection added to
augment the reliability and internal validity. The primary data
collection uses information categories that genuinely tap added
distinctions and opinions that relate to it to build the weight of
evidence from first-hand sources and substantiate the initial
hypotheses about the program phenomenon and its differences from a
typical research portfolio of individual and insular projects.
The synthesized results across primary and secondary data sources
will provide critical insights on transformativeness of high-impact,
trans-NIH programs and contribute important information about the
synergies and collaborations in multi-component scientific research. It
will also identify areas for program improvement and lessons learned
that might be useful to other research programs of the Agency.
To reduce response bias and to make the survey as accessible as
possible to busy principal investigators, the survey will be Web-based.
Frequency of Response: Once.
Affected Public: Principal Investigators of the program at not-for-
profit institutions.
Type of Respondents: Principal Investigators.
The annual reporting burden is as follows:
Estimated number of Respondents: 53.
Estimated Number of Responses per Respondent: 1.
Average Burden Hours Per Response: 0.33.
Estimated Total Annual Burden Hours Requested: 17.49.
The annualized cost to respondents is estimated at: $891.99.
There are no Capital Costs, Operating Costs and/or Maintenance
Costs to report.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Frequency of Annual burden
Type of respondent Number of responses per Average burden hours per hours
respondents respondent response requested
----------------------------------------------------------------------------------------------------------------
Principal Investigators............... 53 1 0.33 (20 minutes)....... 17.49
----------------------------------------------------------------------------------------------------------------
Request for Comments: Written comments and/or suggestions from the
public and affected agencies are invited on one or more of the
following points: (1) Whether the proposed collection of information is
necessary for the proper performance of the function of the agency,
including whether the information will have practical utility; (2) The
accuracy of the agency's estimate of the burden of the proposed
collection of information, including the validity of the methodology
and assumptions used; (3) Ways to enhance the quality, utility, and
clarity of the information to be collected; and (4) Ways to minimize
the burden of the collection of information on those who are to
respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
For Further Information Contact: To request more information on the
proposed project or to obtain a copy of the data collection plans and
instruments, contact Genevieve deAlmeida-Morris, PhD, M.P.H., Project
Officer, Office of Science Policy and Communications, NIH/NIDA, NSC--
Neuroscience Center, 5229, 6001
[[Page 13649]]
Executive Blvd., Rockville, MD 20852 or call non-toll-free number 301-
594-6802 or e-mail your request including your address to:
dealmeig@nida.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 60-days
of the date of this publication.
Dated: March 8, 2011.
Mary Affeldt,
Executive Officer (OM Director), NIDA.
[FR Doc. 2011-5786 Filed 3-11-11; 8:45 am]
BILLING CODE 4140-01-P
